Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It has been http://plandaibiotech.com/plandai-biotech-investor2012.pd
which has been the Investor Fact Sheet in 20122. Unfortunately management deleted this link (not wondering at all as those prediction has been made to get investor into the stock), but I have a print matter as I got in 2012 already. This says $ 43.000.000 in 2013.
Believe it or not. Not my fault management deleted early releases. By the way, even release of 2013 and 2012 can not be found anymore. Not pleasing IMO. There is nothing to hide.
They did: 43 million per year - for a start only. But I would have prefered not to read such predictions in early 2013 as I would not be astonished to be disappointed again about any new prediction. I learned: Never believe any prediction of revenues by a start-up - it is all garbage LOL
What? How shall PLPL have revenues figures 2014 if they start production only this week?
Sorry, misunderstanding
Questionable view.
Great for you....but I am not a daytrader! I am not interested in this kind of speculation at all - as I also have not fun to spend my life with daytrading. Additionally, if I would have been a day trader I would not have bought PLPL at .12 and kept it until today.
I do not think that blaming PLPL for three good news releases per week "only" makes the chart looking better: Monday: Shively gets in, Tuesday: Shively gets vice-president, Wednesday: Shively takes over PLPL, Thursday: Shively makes 1.7 billion smoking Phyrofare-pot, Friday: Shareholder of PLPL get out with $80 per share. No question, this is what would happen. LOL
Great? Can't agree after red days in succession. Sounds like calculated optimism
We have got brillant news nearly every day - what else shall we ask? Just to get up the price for two days and than watch it down again? I want nothing but real product sales contracts and revenues.................... and this we will get in some months only. We should be enormously lucky if the prices moves sidewards for the coming months.
We should have tiny realism in any hopes ! Otherwise we will be lost by all those shareolder who turn to get negative just because the price does not go ten bucks within a week.
Thank you regarding your opinion about HH, Jimbo !! But we will be the big lossers not HH.
unfortunately market is full of stock dummies buying at great news and sell if they worry there is not great news every 5 minutes. But in case of news every 5 minutes they worry this news could be pump.....and so on. Pennystock is pennystock and does not function logical. Thus it is all just hope until a company delivers revenues which makes a story a bit more stable and trustworthy. PLPL is on a good way beside a good story - but still volatile in every case.
My advice is to keep shares as the company is definitively based on solid informations! Earnings should be apparent first Q 2014 - not end of 2014 !
Every stock is based on sentiment, expections and especially on speculation - what else?
Shorts dump - daytrader gamble - longs stay. This is all speculation. Period.
There are foreign investors here as well, so please take this into account if you or anybody else posts any inforations or articles published in the USA. Some don't know those articles and thus they are not 'old' at all just because posted one day later ! How shall a foreigner find all those numberless and important articels? We also have a job and can't hang all day at the screen for doing endless DD.
I think shorts simply use everything tiny negative as longs simply use everything tiny positiv. It is a question which segment you are trading in - unfortunately microcap segment is the most dangerous one and thus shorts feel fine there. They just wait for bubbles, dilution, hypes, delays in progress, etc.etc. - an easy game - nothing to be called 'smart'.
Longs are playing with fire as well......as 90% of pennystocks/microcaps are pure fire if kept too long. PLPL hopefully plays in another League - currently it seems so - thus short selling could really be dangerous sometimes regarding PLPL.
If I understand you right, you want to say: All press releases about marijuana by Plandai have been untrue - as well as the license agreement with the marijuana company Pellier - because you did not find the word marijuana in the 10Q of end of 2013 of Plandai?
Have to correct myself: You are right, Pellicer has been mentioned. Nevertheless I have no problems with the fact that a license for such an important and famous name, has to cost money. I am even astonished that Pellicer did not receive those 5 mm shares for free - which weould not be unusual at all. Thus a price of 0.01 per shares is nothing but a theoretical perchase price for the book keeping. I prefer the name Pellicer in connection with Plandai ....insteed of a totally unknow Plandai which would have to fight for years until the world gets used to this companies name. I do not understand the problem with such a license and such a price! Maybe Plandai should ask GlaxoSmithKline for a license using their name....guess Plandai would have to offer 100 billion shares for .01 for such a licence.
And I would love it also ! Names and reputation costs money - that simple!
Marvelous !!!!!!!!!!!!!!!
- 25mm new shares ...... I count 18.5 million only ! Please correct me - page at 10Q. However, an acceptable and low dilution after two years.
- cash is down............. it is a start-up!
- Sales down.................has been reasonable clarified
- Expenses way up............it is a start-up
- Lots of cheap shares to the CEO......page please
- 5 million warrants at 1c to Pellicer ..............page please as I have not been able to find the name 'Pellicer'. Thank you.
I prefer to stay and watch the story grow - as wsell as the value of my plpl shares. In and out and in and out etc.etc.etc .... waste of time for some $ only. I am happy I did accumulate in early 2013.
My take is that some 'news' are informations, not news. And in this case it is , of course, an important part of the whole picture and IMO of course helpful - if people can read.
"Details" you may find here ( from the blog of PLPL website):
Michael Williams
Posted February 13, 2014
Hallo, I take the liberty to ask threee qestions:
1st
Plandai promised revenues in 2013 which finally unfortunately did not have been generate. When are significant revenues in sight to help confidence in Plandai?
2nd
I am astonished than never any pictures are shown from the inside of the farm building with all machines ready for production. It is nearly 7 months ago that always an empty facility is shown! Why?
3rd
All those deals in the news are great. But when is Plandai able to prove that Phytofare will be more than just a promise and will be accepted by the FDA?
Thank you for your reply.
Plandaí PR
Posted February 13, 2014
Michael,
Thanks for taking the time to ask three very valid questions.
It would be my pleasure to answer them.
1: With the processing and extraction facility coming online shortly we expect therefore to show revenues during 2014. The factory should come online in Q1 with revenues from the sale of extract commencing soon thereafter.
2: Due to the proprietary nature of the technology putting picture of the inside of the factory online could potentially assist our competitors. I will talk to legal and see what pictures are suitable and get it posted to the blog.
3:We expect to have clinical results during Q1 of this year with further trials due to commence during 2014 which will solidify us as the dominant player in our field. With respect to being “accepted by the FDA”, we are not presently pursuing any Phase III human clinical trials for drug targets. No drugs are ever “accepted by the FDA.” A company can receive clearance to market drugs to treat specific conditions but only after Phase III clinical trials are completed and application made to the FDA. We will publish our clinical results as they come available and will commence selling Phytofare as a nutriceutical ingredient as we evaluate their potential for future FDA clearance.
Please feel free to ask as many questions as you like and we truly do appreciate your loyalty as a shareholder.
With FDA approval this flies much much higher than $ 3.5 if the compnay keeps dilution low at an acceptable level............even I avoid predictions, dreams and illusions. But a FDA approval opens all possibilities regarding Phytofare and numberless business connections. But...still to early to predict anything in this direction.
I like PLPL of course, but do not keep my eyes wide shut - so IMO this chart analysis is much too theoretical as microcaps without revenues, mainly debt and with products still in FDA approval are enormously volatile. I think this chart analysis is not trustworthy at all ... but looking nice of course.
Revenues of $ 48.000.000 in 2013 ..............Guess PLPL has not been able to file in time because counting all those coins takes months .... well, just my very personal optimism
BTW a saucerful of humour would be helpful for some here. Don't forget, those who got it between 2.00 and 3.00 must have tears in their eyes. My wish for them is to get their money back. PLPL is good enough for this minimum.
GLTA from a successfull pessimist
Have a nice sunday.
serious money and serious stocks are two pairs of shoes. The clown is in pennystocks since approx. two decades, bought himself an AM by selling www-pennystocks in spring 2000 - 90% non-serious ones BTW - and holds 1/4 m shares of PLPL since 2012 - and this even he never has been drinking alcohol since 4 decades. Well, true, I must be naiv , thanks for this compliment: Better to be naiv than to be an 'unsuccessful optimist' LOL
BTW, nice board here, full of millionaires LOL
agree, unsuccessful optimism sounds more charming
Oh, sure,I like dramas related to the stockmarket..... especially 'No Exit' by Satre - an accurate description for the unsuccessful greed of 95% of all pennystock speculators.... All hypes, pumps, bash and promotion is nothing but useless penny dramas anyway. Thus I am in respectable society
thanks! Finally someone with a bit of humour here in this enormously 'serious' stockmarket LOL (ask myself what the hell is serious at all at pennystocks)
Happy sunday!
Sometimes I must laugh: Shively is looking worse than my grandma has been looking when she was 80 - just a totally boring and conservative guy wants to deal with pot LOL
World is wild. But I hope he will make it - maybe BECAUSE he looks boring and nobody believes he could also be smoking pot ;---)
So: Go Shively and make PLPL big !
if I always would worry about short seller I would have to stay out of every microcap. There are pros and cons against such stocks.....but not using the current great news is more questionable than to fear short seller. Either I have gut to speculate with microcaps or I don't . I stay in PLPL - too curious and much too interesting how everything develops. I am happy I decided 15 months ago to get in. I can stay another 15 months ;----)
obviously finally before weekend starts stockmarket got a brain...........
Disappointing trading
Always a compnay is blamed for this - although the market is full of MMs, daytreader, gambler, short seller, and stockmarket meber who got in with a hype and do not touch the compnay anymore after they have burned their fingers by buying directly into the coverage of short seller and a deep drop aferwards. The market is full of idiots and hard boiled gambler. It must not always be the number of shares which hammers the chart! I assume tit will be the next argument of basher that Plandai is floating with shares (guess this would anyway NOT be in the interest of Shively! Why should he become a director of such a microcap?!?!? ) the market and than people run out again.....even a rich ex-director of Microsoft is part of the BOD.
Humans are dump, that simple.
No shareholder of ex-SPKL knows ! Still holding a bunch without value. Do not believe it will be worth anything in near future. Maybe CPFI does a split and our shares are even less worth. Nobody should be dreaming, here is nothing to win for old longs of SPKL
Organized crime- this is how this is called Herzog & Co. have done !
Herzog in jail to rot there his last years.
Disappointing reaction by the market. Obvioulsy people are still that stupid to buy on a three day hype only and the hype is over and reall great news get in they are too stupid to make real money.
Stockmarket is very stupid. That's why I prefer my job and understand that stockmarket has no seriousity at all.
Hope shareholder of PLPL make money finally and screw the stockmarket like the big ones do. GLTA
Seldom thrilled - today I am !
W O W !!! Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively to Board of Directors
Today : Thursday 13 February 2014
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively to Board of Directors
NEW YORK, NY--(Marketwired - Feb 13, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has named Jamen Shively, a leading voice in the burgeoning marijuana industry and co-founder of the Diego Pellicer group of companies, to its Board of Directors. Mr. Shively will be filling the vacancy created with the resignation of David Rzepnicki, who recently resigned.
Roger Duffield, Chief Executive Officer of Plandaí, commented on the appointment of Mr. Shively to the Board, "Jamen brings a wealth of experience in both engineering and branding to Plandaí not to mention his bold leadership in the cannabis field. As a member of Plandaí's Board, Jamen will be instrumental in helping shape our corporate policy and direction as we move from being a research company into production and sales in the coming months."
Jamen Shively, age 45, has a background in engineering and marketing, with specialties in artificial intelligence, the modeling and optimization of complex networks, and the creation and positioning of new categories of products and services. Jamen co-founded Diego Pellicer Inc. in 2012, and built the brand from zero to the #1 most recognized brand of cannabis in the world in less than one year. Prior to founding Diego Pellicer, Jamen worked for Microsoft from 2003 to 2009 as Corporate Strategy Manager, where he focused on the creation and development of new categories of software products and online services. Preceding his Microsoft career he headed Shively International Inc., which built and operated both cybercafés and educational computer centers in Mexico. Just prior to founding Diego Pellicer Inc., Jamen founded and headed the online marketplace for the specialty food industry, Findood, winning first place in the Northwest Entrepreneur Network's First Look Forum Competition for the top new startup in 2010. Jamen completed his undergraduate work at U.C. Berkeley in Civil Engineering, and did graduate work at M.I.T. and U.C. Berkeley in Civil Engineering and Materials Science. He is a Fellow of the National Science Foundation.
Mr. Duffield added, "We are grateful for the years of service Mr. Rzepnicki provided to myself and to Plandaí over the past decade. He was one of the first to grasp the vision of the company and has been an unflagging ally over the years. As he focuses on his family and other business opportunities, we extend our sincerest thanks."
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its patented Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.
Contact:
Andrew Beyer
Phone: 619-202-7456
Email: investor@Plandaíbiotech.com
tomatotom, PLandai doesn't have enough money to go NASDAQ, SEC filings cost a hell of money and rules are enormous. DD of Institutions is much more intensive and institution buy because of a really existing product which generates significant revenues already. PLPL is still not ready for this till this summer as well as Phytofare needs to receive FDA approval before. No microcap - which has been a shell before - has a chance to go NASDAQ within two years only !